GGrantIndex
Sort

261,768 grants matching gene therapy

MRI, GENETIC AND COGNITIVE PRECURSORS OF AD AND DEMENTIA

$923,936
Boston University Medical Campus · R01 · FY2001 · AG

Molecular Therapy Core Centers

$923,927
University Of Washington · P30 · FY2005 · DK

Clinical Evaluation of a Novel Prostate Cancer PET Diagnostic

$923,913
Beatrice Langton-Webster · Cancer Targeted Technology, Llc · R44 · FY2016 · CA

Regulation of Lymphocyte Proliferation and Replicative Capacity

$923,719
Richard J. Hodes · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

JACKSON HEART STUDY

$923,597
Asoka S Srinivasan · Tougaloo College · N01 · FY2009 · HL

Polymerase theta, genome instability, and cancer

$923,490
Dale A Ramsden · Univ Of North Carolina Chapel Hill · P01 · FY2021 · CA

p53-mediated metabolic regulation in tumor suppression

$923,400
Wei Gu · Columbia University Health Sciences · R35 · FY2024 · CA

Exploring DNA damage response pathways as targets for cancer therapy

$923,400
Junjie Chen · University Of Tx Md Anderson Can Ctr · R35 · FY2024 · CA

Improving drug design to eliminate side effects: From computational to animal models

$923,348
C. Denise Okafor · Pennsylvania State University, The · DP2 · FY2025 · GM

The University of Southern California and Buck Institute Nathan Shock Center

$923,307
Eric M Verdin · Buck Institute For Research On Aging · P30 · FY2023 · AG

The University of Southern California and Buck Institute Nathan Shock Center

$923,306
Eric M Verdin · Buck Institute For Research On Aging · P30 · FY2021 · AG

The University of Southern California and Buck Institute Nathan Shock Center

$923,306
Eric M Verdin · Buck Institute For Research On Aging · P30 · FY2022 · AG

The University of Southern California and Buck Institute Nathan Shock Center

$923,306
Eric M Verdin · Buck Institute For Research On Aging · P30 · FY2024 · AG

The University of Southern California and Buck Institute Nathan Shock Center

$923,306
Eric M Verdin · Buck Institute For Research On Aging · P30 · FY2020 · AG

Molecular Epidemiology of Colorectal Cancer

$923,263
Stephen B Gruber · University Of Michigan At Ann Arbor · R01 · FY2008 · CA

Data Processing, Analysis and Modeling Unit

$923,254
Jeremy Goecks · Oregon Health & Science University · U2C · FY2023 · CA

Omic and Multidimensional Spatial Atlas of Metastatic Breast Cancer

$923,254
Emek Demir · Oregon Health & Science University · U2C · FY2023 · CA

NCMRR-DC Core Molecular & Functional Outcome Measures in Rehabilitation Medicine

$923,220
Eric P Hoffman · Children'S Research Institute · R24 · FY2012 · HD

Pediatric Oncology Clinical Research Training Program

$923,163
Susan M Blaney · Baylor College Of Medicine · K12 · FY2020 · CA

Human Polycystic Kidney Disease

$923,157
University Of Colorado Denver · P01 · FY2001 · DK

Novel Targets for Vaccine Therapy

$923,127
Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA

Therapeutic Targeting of Malignant Glioma Stem Cells

$923,113
Maciej S Lesniak · Northwestern University At Chicago · R35 · FY2016 · CA

Phenotype MicroArray Analysis of Fastidious Pathogens

$923,041
Barry Ronald Bochner · Biolog, Inc. · R42 · FY2009 · GM

APOL1 - associated nephropathy from human-derived, intrarenal perspective

$922,998
Matthew Gordon Sampson · Boston Children'S Hospital · R01 · FY2025 · DK

Participant Engagement Unit

$922,915
Andrew Louis Sussman · University Of New Mexico Health Scis Ctr · U2C · FY2025 · CA